Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +51.75%
#3 DOVU DOVU +48.15%
#4 Black Phoenix Black Phoenix +34.08%
#5 Velvet Velvet +33.34%
#6 Cross Cross +29.27%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.47%
#8 OVERTAKE OVERTAKE +15.82%
#9 Bitway Bitway +15.10%
#10 QANplatform QANplatform +14.50%
Coin of the day
Glidr Glidr
설정
언어
한국어
통화
USD
테마
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
주식 순위 #38793
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
주가
$0.099
시가총액
$801.50K
변동 (1일)
0.00%
변동 (1년)
-34.44%
국가
US
거래 ZyVersa Therapeutics, Inc. (ZVSA)

카테고리

Healthcare
ZyVersa Therapeutics, Inc. (ZVSA)의 주가 이력
최고 종가: $0.11 (2026-08-01 기준)

최저 종가: $3.45K (2022-02-01 기준)
ZyVersa Therapeutics, Inc.의 주가 이력 (2022 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 21.33%
2025 -87.48%
2024 -90.24%
2023 -99.49%
2022 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.29 29.97%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $848.63 30.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE